Azenta, Inc. (Nasdaq: AZTA) today announced that Dipal Doshi, Chief Executive Officer of Entrada Therapeutics (NASDAQ: TRDA) ...

BURLINGTON, Mass. - Azenta, Inc. (NASDAQ: AZTA), a global provider of life sciences solutions, announced the election of ...

Azenta, Inc. (NASDAQ:AZTA), a company specializing in special industry machinery with a market capitalization of $2.46 billion, announced today that it has classified its B Medical (TASE:PMCN) Systems ...

Azenta, Inc. (Nasdaq: AZTA) will announce fiscal first quarter 2025 earnings which ended on December 31, 2024, on Wednesday ...

Azenta, Inc. shares have surged over 30% since Nov 2024 due to S&P 600 inclusion and an analyst upgrade, despite somewhat ...

The UK Biocentre in Milton Keynes is set to enhance its large-scale biomedical research capabilities with the addition of a new high-density automated storage system. The BioArc Ultra, developed ...

Azenta (AZTA) announced that it has been selected as the technology provider by UK Biocentre as they expand their large-scale sample storage in ...

Shares of Azenta, Inc. (NASDAQ: AZTA) rose on Tuesday after the company reported better-than-expected fourth-quarter financial results.

Real time quote data is not available at this time. *Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...